About: Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1994

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1994 (uk) article scientifique publié en 1994 (fr) im Mai 1994 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1994 (ast) scientific article published on 01 May 1994 (en)
publication date	wds:Q72410741-727DB2F3-74F5-4E8A-A21F-E053AA785F49
publication date	1994-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72410741-D8F290E1-FA90-47F9-BA88-76837715A9CE
language of work or name	English
cites work	wds:Q72410741-0A630858-97AE-4DFF-BE21-157377D300BD wds:Q72410741-213D6D51-6933-4B08-AD32-3D2434EDF150 wds:Q72410741-70EFF524-DCA0-41B2-9C83-225ADFFD5C08 wds:Q72410741-7716E5B8-03B7-40C3-ADFF-F3719DDD51EB wds:Q72410741-976957C6-634C-43C9-A02F-D7F878601149 wds:Q72410741-B57D80E5-D633-4C0E-A3D2-356A2039ACCC wds:Q72410741-C1FFC994-1E76-4E4C-B3EA-C68B3A6535D2 wds:Q72410741-C6A2A5D5-2E86-4B15-985A-0F1827412A39 wds:Q72410741-E2A32BA3-596B-4F5B-B18C-E1D59C4C6EE2
cites work	Hormone therapy to prevent disease and prolong life in postmenopausal women The benefits and risks of hormone replacement therapy: An epidemiologic overview A risk-benefit assessment of estrogen therapy in postmenopausal women Endometrial Histology and Biochemistry in Climacteric Women during Oestrogen and Oestrogen/Progestogen Therapy Quantitative Computed Tomography of Vertebral Spongiosa: A Sensitive Method for Detecting Early Bone Loss After Oophorectomy The cancer question: an overview of recent epidemiologic and retrospective data Continuous estrogen/progestin therapy in menopause Long-term consequences of estrogen and estrogen-progestin replacement A new combination of conjugated equine oestrogens and medroxyprogesterone for treatment of climacteric complaints
author name string	wds:Q72410741-2115D92B-E610-4AF3-AB47-EE5FA3C9BFB4 wds:Q72410741-D6A61539-2A77-4681-B5EE-5B0634AD07AC
author name string	J D Woodruff J H Pickar
rdfs:label	Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (nl) Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group (en)
skos:prefLabel	Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (nl) Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group (en)
name	Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (nl) Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group (en)
title	wds:Q72410741-B31A27DF-61E5-4C09-9191-62BE833163F9
title	Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group (en)
page(s)	wds:Q72410741-722CCBA4-B16B-441C-A46A-02F5A0EB917E
page(s)	1213-1223
instance of	wds:Q72410741-1A33F0CF-7CE0-4F28-87F0-802F8054DF5F
instance of	scholarly article
main subject	wds:Q72410741-2A8BB946-6D7A-4D69-BDE2-84A31A3D3DDB wds:Q72410741-4797E3D7-B72C-414C-B748-9D325106FF7E wds:Q72410741-4981457F-839F-4912-AA81-5ED838BAB38F
main subject	estrogen endometrial hyperplasia medroxyprogesterone acetate
PubMed ID	wds:Q72410741-43A0A926-BD12-4A10-B815-32C92FE9765E
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8178840
PubMed ID	8178840
published in	wds:Q72410741-6EE4D758-0821-4800-A652-F4E474BEF8E3
published in	American Journal of Obstetrics and Gynecology
issue	wds:Q72410741-785E7287-7699-4C0F-81CF-3694E9048646
volume	wds:Q72410741-BCA85492-D7CD-4183-923D-216904713BE4
issue	5 Pt 1
volume	170
DOI	wds:Q72410741-84571F00-7A10-470A-9E3A-91BCCC512A87
DOI	http://dx.doi.org/10.1016/S0002-9378(94)70129-6
DOI	10.1016/S0002-9378(94)70129-6
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72410741
is cites work of	Hormonal replacement therapy Hormone therapy in postmenopausal women and risk of endometrial hyperplasia Endometrial response to IVF hormonal manipulation: comparative analysis of menopausal, down regulated and natural cycles Diagnosis and therapy of hyperandrogenism Coordinate Regulation of the Production and Signaling of Retinoic Acid by Estrogen in the Human Endometrium The menopause Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: a randomized trial Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy Is bleeding a predictor of endometrial hyperplasia in postmenopausal women receiving hormone replacement therapy? Menopause Study Group (United States, Italy, Netherlands, Switzerland, Belgium, Germany, and Finland A practical guide to prescribing hormone replacement therapy Progestins in the menopause HRT, breast and endometrial cancers: strategies and intervention options. Effect of hormone replacement therapy on postmenopausal endometrial bleeding Hormone therapy in postmenopausal women and risk of endometrial hyperplasia Oral micronized progesterone Endometrial safety of continuous combined hormone replacement therapy with 17beta-oestradiol (1 or 2 mg) and dydrogesterone Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism Endometrial histology and bleeding patterns in post-menopausal women taking sequential, combined estradiol and dydrogesterone Clinical pharmacology of selective estrogen receptor modulators Estrogen with interrupted progestin HRT: a review of experimental and clinical studies Hormone replacement therapy and the endometrium The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis The menopause and its treatment in perspective Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995. Soy isoflavone supplementation and bone mineral density in menopausal women: a 2-y multicenter clinical trial Menopause and hormone replacement Cardiovascular pharmacology of hormone replacement therapy Neoplasia of the female reproductive tract: effects of hormone therapy Endometrial glandular proliferation and estrogen receptor content during the normal menstrual cycle Cell cycle analysis and detection of proliferative cell nuclear antigen of the endometrium after hormone replacement therapy

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software